Melatonin and the skeleton

Osteoporosis International

Volumn 24, Issue 12, 2013, Pages 2919-2927

  Amstrup, A K ^a   Sikjaer, T ^a   Mosekilde, L ^a   Rejnmark, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Melatonin; Osteoblast; Osteoclasts; Osteoporosis; Review; Skeleton

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLONY STIMULATING FACTOR 1; ESTRADIOL; MELATONIN; MELATONIN 2 RECEPTOR; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACEBO; PROCOLLAGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCAVENGER; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; ADOLESCENT IDIOPATHIC SCOLIOSIS; AGE; ANOREXIA; APOPTOSIS; BONE CELL; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CIRCADIAN RHYTHM; DRUG MEGADOSE; ENDURANCE TRAINING; EVENING DOSAGE; FRAGILITY FRACTURE; HORMONE SUBSTITUTION; HUMAN; IDIOPATHIC SCOLIOSIS; IMMOBILITY; IN VITRO STUDY; JET LAG; KLINEFELTER SYNDROME; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; OXIDATIVE STRESS; PINEALECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHIFT WORKER; SKELETON; SMITH MAGENIS SYNDROME; WNT SIGNALING PATHWAY;

ANIMALS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; HUMANS; MELATONIN; OSTEOGENESIS; OSTEOPOROSIS; OXIDATIVE STRESS; SCOLIOSIS;

EID: 84890425075     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2404-8     Document Type: Review

References (100)

1. Stehle JH, Saade A, Rawashdeh O, Ackermann K, Jilg A, Sebesteny T, Maronde E (2011) A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 51:17-43
2. Dubocovich ML, Markowska M (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27:101-10
3. Tan DX, Manchester LC, Reiter RJ, Qi WB, Zhang M, Weintraub ST, Cabrera J, Sainz RM, Mayo JC (1999) Identification of highly elevated levels of melatonin in bone marrow: Its origin and significance. Biochim Biophys Acta 1472:206-14
4. Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni JM (2000) Evidence for melatonin synthesis in mouse and human bone marrow cells. J Pineal Res 28:193-202
5. Dijk DJ, Duffy JF, Riel E, Shanahan TL, Czeisler CA (1999) Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. J Physiol 516(Pt 2):611-27
6. Redman J, Armstrong S, Ng KT (1983) Free-running activity rhythms in the rat: Entrainment by melatonin. Science 219:1089-91
7. Simonneaux V, Ouichou A, Pevet P (1990) Vasoactive intestinal peptide stimulates melatonin release from perifused pineal glands of rats. J Neural Transm Gen Sect 79:69-79
8. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT (2012) Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol Cell Endocrinol 351:152-66
9. von Gall C, Stehle JH, Weaver DR (2002) Mammalian melatonin receptors: Molecular biology and signal transduction. Cell Tissue Res 309:151-62
10. Sethi S, Radio NM, Kotlarczyk MP, Chen CT, Wei YH, Jockers R, Witt-Enderby PA (2010) Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways. J Pineal Res 49:222-38
11. Satomura K, Tobiume S, Tokuyama R, Yamasaki Y, Kudoh K, Maeda E, Nagayama M (2007) Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo. J Pineal Res 42:231-39
12. Masana MI, Doolen S, Ersahin C, Al-Ghoul WM, Duckles SP, Dubocovich ML, Krause DN (2002) MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 302:1295-302
13. Krause DN, Barrios VE, Duckles SP (1995) Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 276:207-13
14. Cagnacci A, Elliott JA, Yen SS (1992) Melatonin: A major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab 75:447-52
15. Grossman E, Laudon M, Zisapel N (2011) Effect of melatonin on nocturnal blood pressure: Meta-analysis of randomized controlled trials. Vasc Health Risk Manag 7:577-84
16. Esquifino AI, Villanua MA, Agrasal C (1987) Effect of neonatal melatonin administration on sexual development in the rat. J Steroid Biochem 27:1089-93
17. Maestroni GJ, Conti A, Pierpaoli W (1986) Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol 13:19-30
18. Esteban S, Garau C, Aparicio S, Moranta D, Barcelo P, Fiol MA, Rial R (2010) Chronic melatonin treatment and its precursor l-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J Pineal Res 48:170-177
19. Martinez-Campa C, Gonzalez A, Mediavilla MD, Alonso-Gonzalez C, Alvarez-Garcia V, Sanchez-Barcelo EJ, Cos S (2009) Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br J Cancer 101:1613-19
20. Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH (1975) Daily rhythm in human urinary melatonin. Science 187:169-71
21. Waldhauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M, Schemper M, Frisch H (1988) Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 66:648-52
22. Waldhauser F, Weiszenbacher G, Frisch H, Zeitlhuber U, Waldhauser M, Wurtman RJ (1984) Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet 1:362-65
23. Zhdanova IV, Wurtman RJ, Balcioglu A, Kartashov AI, Lynch HJ (1998) Endogenous melatonin levels and the fate of exogenous melatonin: age effects. J Gerontol A Biol Sci Med Sci 53:B293-B298
24. Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM (1986) Human melatonin production decreases with age. J Pineal Res 3:379-88
25. Karasek M (2004) Melatonin, human aging, and age-related diseases. Exp Gerontol 39:1723-29
26. Yocca FD, Friedman E (1984) Effect of immobilization stress on rat pineal beta-adrenergic receptor-mediated function. J Neurochem 42:1427-32
27. Carr DB, Reppert SM, Bullen B, Skrinar G, Beitins I, Arnold M, Rosenblatt M, Martin JB, McArthur JW (1981) Plasma melatonin increases during exercise in women. J Clin Endocrinol Metab 53:224-25
28. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S (1995) Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab 80:3304-10
29. Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L (1997) Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 60:419-23
30. Sairanen S, Tahtela R, Laitinen K, Karonen SL, Valimaki MJ (1994) Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin. Calcif Tissue Int 55:349-52
31. Zhang L, Su P, Xu C, Chen C, Liang A, Du K, Peng Y, Huang D (2010) Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARgamma expression and enhancing Runx2 expression. J Pineal Res 49:364-72
32. Nakade O, Koyama H, Ariji H, Yajima A, Kaku T (1999) Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 27:106-10
33. Park KH, Kang JW, Lee EM, Kim JS, Rhee YH, Kim M, Jeong SJ, Park YG, Kim SH (2011) Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J Pineal Res 51:187-94
34. Roth JA, Kim BG, Lin WL, Cho MI (1999) Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 274:22041-47
35. Koyama H, Nakade O, Takada Y, Kaku T, Lau KH (2002) Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res 17:1219-29
36. Histing T, Anton C, Scheuer C, Garcia P, Holstein JH, Klein M, Matthys R, Pohlemann T, Menger MD (2012) Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. J Surg Res 173:83-90
37. Chen YH, Xu DX, Wang JP, Wang H, Wei LZ, Sun MF, Wei W (2006) Melatonin protects against lipopolysaccharide-induced intra-uterine fetal death and growth retardation in mice. J Pineal Res 40:40-47
38. Oktem G, Uslu S, Vatansever SH, Aktug H, Yurtseven ME, Uysal A (2006) Evaluation of the relationship between inducible nitric oxide synthase (iNOS) activity and effects of melatonin in experimental osteoporosis in the rat. Surg Radiol Anat 28:157-62
39. Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 314:197-207
40. Li M, Zhao L, Liu J, Liu AL, Zeng WS, Luo SQ, Bai XC (2009) Hydrogen peroxide induces G2 cell cycle arrest and inhibits cell proliferation in osteoblasts. Anat Rec (Hoboken) 292:1107-13
41. Mody N, Parhami F, Sarafian TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509-19
42. Radio NM, Doctor JS, Witt-Enderby PA (2006) Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 40:332-42
43. Sethi S, Radio NM, Kotlarczyk MP, Chen CT, Wei YH, Jockers R, Witt-Enderby PA (2010) Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways. J Pineal Res 49:222-38
44. Canalis E (2009) Growth factor control of bone mass. J Cell Biochem 108:769-77
45. Picinato MC, Hirata AE, Cipolla-Neto J, Curi R, Carvalho CR, Anhe GF, Carpinelli AR (2008) Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J Pineal Res 44:88-94
46. Ostrowska Z, Kos-Kudla B, Swietochowska E, Marek B, Kajdaniuk D, Ciesielska-Kopacz N (2001) Influence of pinealectomy and long-term melatonin administration on GH-IGF-I axis function in male rats. Neuro Endocrinol Lett 22:255-62
47. Bell NH (2001) Advances in the treatment of osteoporosis. Curr Drug Targets Immune Endocr Metabol Disord 1:93-102
48. Blair HC, Athanasou NA (2004) Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 19:189-99
49. Reiter RJ, Tan DX, Qi W, Manchester LC, Karbownik M, Calvo JR (2000) Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 9:160-171
50. Matuszak Z, Reszka K, Chignell CF (1997) Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic Biol Med 23:367-72
51. Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland R (2002) Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2:181-97
52. Baek KH, Oh KW, Lee WY, Lee SS, Kim MK, Kwon HS, Rhee EJ, Han JH, Song KH, Cha BY, Lee KW, Kang MI (2010) Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 87:226-35
53. Bax BE, Alam AS, Banerji B, Bax CM, Bevis PJ, Stevens CR, Moonga BS, Blake DR, Zaidi M (1992) Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 183:1153-58
54. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288:275-79
55. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852-59
56. Ozler M, Simsek K, Ozkan C, Akgul EO, Topal T, Oter S, Korkmaz A (2010) Comparison of the effect of topical and systemic melatonin administration on delayed wound healing in rats that underwent pinealectomy. Scand J Clin Lab Invest 70:447-52
57. Sahna E, Parlakpinar H, Vardi N, Cigremis Y, Acet A (2004) Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. Acta Histochem 106:331-36
58. Gilad E, Wong HR, Zingarelli B, Virag L, O'Connor M, Salzman AL, Szabo C (1998) Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NFkappaB activation. FASEB J 12:685-93
59. Crespo E, Macias M, Pozo D, Escames G, Martin M, Vives F, Guerrero JM, Acuna-Castroviejo D (1999) Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide- induced multiple organ dysfunction syndrome in rats. FASEB J 13:1537-46
60. Cardinali DP, Ladizesky MG, Boggio V, Cutrera RA, Mautalen C (2003) Melatonin effects on bone: Experimental facts and clinical perspectives. J Pineal Res 34:81-87
61. Altindag O, Erel O, Soran N, Celik H, Selek S (2008) Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 28:317-21
62. Sheweita SA, Khoshhal KI (2007) Calcium metabolism and oxidative stress in bone fractures: Role of antioxidants. Curr Drug Metab 8:519-25
63. Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14:129-35
64. Suzuki N, Hattori A (2002) Melatonin suppresses osteoclastic and osteoblastic activities in the scales of goldfish. J Pineal Res 33:253-58
65. Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D, Ciesielska-Kopacz N (2002) The relationship between the daily profile of chosen biochemical markers of bone metabolism and melatonin and other hormone secretion in rats under physiological conditions. Neuro Endocrinol Lett 23:417-25
66. Ladizesky MG, Boggio V, Albornoz LE, Castrillon PO, Mautalen C, Cardinali DP (2003) Melatonin increases oestradiol-induced bone formation in ovariectomized rats. J Pineal Res 34:143-51
67. Cos S, Gonzalez A, Martinez-Campa C, Mediavilla MD, Alonso-Gonzalez C, Sanchez-Barcelo EJ (2006) Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 30:118-28
68. Ladizesky MG, Cutrera RA, Boggio V, Somoza J, Centrella JM, Mautalen C, Cardinali DP (2001) Effect of melatonin on bone metabolism in ovariectomized rats. Life Sci 70:557-65
69. Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D, Staszewicz P, Szapska B, Strzelczyk J (2002) The influence of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone metabolism in experimental osteoporosis in the rat. Neuro Endocrinol Lett 23(Suppl 1):104-9
70. Uslu S, Uysal A, Oktem G, Yurtseven M, Tanyalcin T, Basdemir G (2007) Constructive effect of exogenous melatonin against osteoporosis after ovariectomy in rats. Anal Quant Cytol Histol 29:317-25
71. Witt-Enderby PA, Slater JP, Johnson NA, Bondi CD, Dodda BR, Kotlarczyk MP, Clafshenkel WP, Sethi S, Higginbotham S, Rutkowski JL, Gallagher KM, Davis VL (2012) Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female mice. J Pineal Res
72. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ (1984) Bioavailability of oral melatonin in humans. Neuroendocrinology 39:307-13
73. Egermann M, Gerhardt C, Barth A, Maestroni GJ, Schneider E, Alini M (2011) Pinealectomy affects bone mineral density and structure - an experimental study in sheep. BMC Musculoskelet Disord 12:271
74. Turgut M, Kaplan S, Turgut AT, Aslan H, Guvenc T, Cullu E, Erdogan S (2005) Morphological, stereological and radiological changes in pinealectomized chicken cervical vertebrae. J Pineal Res 39:392-99
75. Feskanich D, Hankinson SE, Schernhammer ES (2009) Nightshift work and fracture risk: The Nurses' health study. Osteoporos Int 20:537-42
76. Burch JB, Yost MG, Johnson W, Allen E (2005) Melatonin, sleep, and shift work adaptation. J Occup Environ Med 47:893-901
77. Kotlarczyk MP, Lassila HC, O'Neil CK, D'Amico F, Enderby LT, Witt-Enderby PA, Balk JL (2012) Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res 52:414-26
78. Crepaldi G, Romanato G, Tonin P, Maggi S (2007) Osteoporosis and body composition. J Endocrinol Invest 30:42-47
79. Fideleff HL, Boquete H, Fideleff G, Albornoz L, Perez LS, Suarez M, Esquifino AI, Honfi M, Cardinali DP (2006) Gender-related differences in urinary 6-sulfatoxymelatonin levels in obese pubertal individuals. J Pineal Res 40:214-18
80. Shafii M, MacMillan DR, Key MP, Kaufman N, Nahinsky ID (1997) Case study: Melatonin in severe obesity. J Am Acad Child Adolesc Psychiatry 36:412-16
81. Blaicher W, Imhof MH, Gruber DM, Schneeberger C, Sator MO, Huber JC (1999) Endocrinological disorders. Focusing on melatonin's interactions. Gynecol Obstet Invest 48:179-82
82. Blaicher W, Speck E, Imhof MH, Gruber DM, Schneeberger C, Sator MO, Huber JC (2000) Melatonin in postmenopausal females. Arch Gynecol Obstet 263:116-18
83. Ostrowska Z, Ziora K, Kos-Kudla B, Swietochowska E, Oswiecimska J, Dyduch A, Wolkowska-Pokrywa K, Szapska B (2010) Melatonin, the RANKL/RANK/OPG system, and bone metabolism in girls with anorexia nervosa. Endokrynol Pol 61:117-23
84. Lam TP, Hung VW, Yeung HY, Tse YK, Chu WC, Ng BK, Lee KM, Qin L, Cheng JC (2011) Abnormal bone quality in adolescent idiopathic scoliosis: A case-control study on 635 subjects and 269 normal controls with bone densitometry and quantitative ultrasound. Spine (Phila Pa 1976) 36:1211-17
85. Machida M, Dubousset J, Imamura Y, Iwaya T, Yamada T, Kimura J (1995) Role of melatonin deficiency in the development of scoliosis in pinealectomised chickens. J Bone Joint Surg Br 77:134-38
86. Turgut M, Yenisey C, Uysal A, Bozkurt M, Yurtseven ME (2003) The effects of pineal gland transplantation on the production of spinal deformity and serum melatonin level following pinealectomy in the chicken. Eur Spine J 12:487-94
87. Machida M, Dubousset J, Yamada T, Kimura J (2009) Serum melatonin levels in adolescent idiopathic scoliosis prediction and prevention for curve progression - a prospective study. J Pineal Res 46:344-48
88. Brodner W, Krepler P, Nicolakis M, Langer M, Kaider A, Lack W, Waldhauser F (2000) Melatonin and adolescent idiopathic scoliosis. J Bone Joint Surg Br 82:399-403
89. Man GC, Wong JH, Wang WW, Sun GQ, Yeung BH, Ng TB, Lee SK, Ng BK, Qiu Y, Cheng JC (2011) Abnormal melatonin receptor 1B expression in osteoblasts from girls with adolescent idiopathic scoliosis. J Pineal Res 50:395-402
90. Moreau A, Wang DS, Forget S, Azeddine B, Angeloni D, Fraschini F, Labelle H, Poitras B, Rivard CH, Grimard G (2004) Melatonin signaling dysfunction in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 29:1772-81
91. Azeddine B, Letellier K, Wang dS, Moldovan F, Moreau A (2007) Molecular determinants of melatonin signaling dysfunction in adolescent idiopathic scoliosis. Clin Orthop Relat Res 462:45-52
92. Elsea SH, Girirajan S (2008) Smith-Magenis syndrome. Eur J Hum Genet 16:412-21
93. Spilsbury J, Mohanty K (2003) The orthopaedic manifestations of Smith-Magenis syndrome. J Pediatr Orthop B 12:22-26
94. De LH, De Blois MC, Claustrat B, Romana S, Albrecht U, Von Kleist-Retzow JC, Delobel B, Viot G, Lyonnet S, Vekemans M, Munnich A (2001) Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr 139:111-16
95. Boudreau EA, Johnson KP, Jackman AR, Blancato J, Huizing M, Bendavid C, Jones M, Chandrasekharappa SC, Lewy AJ, Smith AC, Magenis RE (2009) Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion. Am J Med Genet A 149A:1382-91
96. Ferlin A, Schipilliti M, Foresta C (2011) Bone density and risk of osteoporosis in Klinefelter syndrome. Acta Paediatr 100:878-84
97. Ferlin A, Schipilliti M, Vinanzi C, Garolla A, Di MA, Selice R, Lenzi A, Foresta C (2011) Bone mass in subjects with Klinefelter syndrome: Role of testosterone levels and androgen receptor gene CAG polymorphism. J Clin Endocrinol Metab 96:E739-E745
98. Luboshitzky R, Wagner O, Lavi S, Herer P, Lavie P (1996) Abnormal melatonin secretion in male patients with hypogonadism. J Mol Neurosci 7:91-98
99. Luboshitzky R, Wagner O, Lavi S, Herer P, Lavie P (1997) Abnormal melatonin secretion in hypogonadal men: The effect of testosterone treatment. Clin Endocrinol (Oxf) 47:463-69
100. Mosekilde L (2008) Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69:1-19